Protagonist Therapeutics
Utility Patents
Last updated:
List of all Protagonist Therapeutics patents 8 in total
| Status | Patent |
|---|---|
Grant | Utility: Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases Filling date: 7 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Filling date: 7 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases Filling date: 7 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Opioid agonist peptides and uses thereof Filling date: 7 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: .alpha.4.beta.7 thioether peptide dimer antagonists Filling date: 7 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Hepcidin analogues and uses thereof Filling date: 7 Sep 2025 Issue date: 10 Dec 2019 |
Grant | Utility: Hepcidin analogues and uses thereof Filling date: 7 Sep 2025 Issue date: 15 Oct 2019 |
Grant | Utility: Methods for synthesizing .alpha.4.beta.7 peptide antagonists Filling date: 7 Sep 2025 Issue date: 10 Sep 2019 |
Showing 1 to 8 of 8 patents.